{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:00:45Z","timestamp":1792486845934,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Health of Japan","award":["Applied Research for Innovative Treatment of Cance"],"award-info":[{"award-number":["Applied Research for Innovative Treatment of Cance"]}]},{"name":"National Cancer Center Research and Development Fund","award":["2020-J-3"],"award-info":[{"award-number":["2020-J-3"]}]},{"name":"National Cancer Center Research and Development Fund","award":["2023-J-03"],"award-info":[{"award-number":["2023-J-03"]}]},{"name":"National Cancer Center Research and Development Fund","award":["2026-J-03"],"award-info":[{"award-number":["2026-J-03"]}]},{"name":"National Cancer Center Research and Development Fund","award":["23-A-19"],"award-info":[{"award-number":["23-A-19"]}]},{"name":"National Cancer Center Research and Development Fund","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}]},{"name":"National Cancer Center Research and Development Fund","award":["29-A-3"],"award-info":[{"award-number":["29-A-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"DOI":"10.1245\/s10434-026-20608-1","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:38:54Z","timestamp":1789997934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007"],"prefix":"10.1245","author":[{"given":"Taichi","family":"Horino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumitsu","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Mitome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-3826","authenticated-orcid":false,"given":"Yukihide","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"issue":"2","key":"20608_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70067","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Wagle NS, Star J, Kratzer TB, Smith RA, Jemal A. Colorectal cancer statistics, 2026. CA Cancer J Clin. 2026;76(2):e70067. https:\/\/doi.org\/10.3322\/caac.70067.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"20608_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1\u201342. https:\/\/doi.org\/10.1007\/s10147-019-01485-z.","journal-title":"Int J Clin Oncol."},{"issue":"4","key":"20608_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ags3.70174","volume":"10","author":"J Takashima","year":"2026","unstructured":"Takashima J, Kobayashi H, Fujimoto D, Miura F. Primary tumor resection in patients with unresectable metastatic colorectal cancer: a systematic review and meta-analysis. Ann Gastroenterol Surg. 2026;10(4):1008\u201320. https:\/\/doi.org\/10.1002\/ags3.70174.","journal-title":"Ann Gastroenterol Surg."},{"key":"20608_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1200\/JCO.20.02447","volume":"39","author":"Y Kanemitsu","year":"2021","unstructured":"Kanemitsu Y, Shitara K, Mizusawa J, et al. Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J Clin Oncol. 2021;39:1098\u2013107. https:\/\/doi.org\/10.1200\/JCO.20.02447.","journal-title":"J Clin Oncol."},{"issue":"1","key":"20608_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ags3.12499","volume":"6","author":"T Horino","year":"2022","unstructured":"Horino T, Tokunaga R, Miyamoto Y, et al. The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection. Ann Gastroenterol Surg. 2022;6(1):83\u201391. https:\/\/doi.org\/10.1002\/ags3.12499.","journal-title":"Ann Gastroenterol Surg."},{"issue":"3","key":"20608_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.23922\/jarc.2023-077","volume":"8","author":"T Horino","year":"2024","unstructured":"Horino T, Tokunaga R, Miyamoto Y, Baba H. Advanced Lung Cancer Inflammation Index: a novel comprehensive biomarker of host status for patients with metastatic colorectal cancer. J Anus Rectum Colon. 2024;8(3):137\u201349. https:\/\/doi.org\/10.23922\/jarc.2023-077.","journal-title":"J Anus Rectum Colon."},{"issue":"6","key":"20608_CR7","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/jcsm.13358","volume":"14","author":"GT Ruan","year":"2023","unstructured":"Ruan GT, Xie HL, Yuan KT, et al. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia. J Cachexia Sarcopenia Muscle. 2023;14(6):2813\u201323. https:\/\/doi.org\/10.1002\/jcsm.13358.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"7","key":"20608_CR8","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/cancers12071986","volume":"12","author":"AS Almasaudi","year":"2020","unstructured":"Almasaudi AS, Dolan RD, Edwards CA, McMillan DC. Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers (Basel). 2020;12(7):1986. https:\/\/doi.org\/10.3390\/cancers12071986.","journal-title":"Cancers (Basel)."},{"issue":"11","key":"20608_CR9","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10552-015-0663-8","volume":"26","author":"HD Woo","year":"2015","unstructured":"Woo HD, Kim K, Kim J. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis. Cancer Causes Control. 2015;26(11):1661\u201370. https:\/\/doi.org\/10.1007\/s10552-015-0663-8.","journal-title":"Cancer Causes Control."},{"key":"20608_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/CMAR.S185350","volume":"11","author":"X Lu","year":"2019","unstructured":"Lu X, Guo W, Xu W, et al. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients. Cancer Manag Res. 2019;11:229\u201349. https:\/\/doi.org\/10.2147\/CMAR.S185350.","journal-title":"Cancer Manag Res."},{"issue":"2","key":"20608_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1053\/j.gastro.2018.05.012","volume":"155","author":"C Gillis","year":"2018","unstructured":"Gillis C, Buhler K, Bresee L, et al. Effects of nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis. Gastroenterology. 2018;155(2):391-410.e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.05.012.","journal-title":"Gastroenterology."},{"issue":"1","key":"20608_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12885-018-5232-6","volume":"19","author":"S van Rooijen","year":"2019","unstructured":"van Rooijen S, Carli F, Dalton S, et al. Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation. BMC Cancer. 2019;19(1):98. https:\/\/doi.org\/10.1186\/s12885-018-5232-6.","journal-title":"BMC Cancer."},{"issue":"3","key":"20608_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s10147-023-02293-2","volume":"28","author":"T Horino","year":"2023","unstructured":"Horino T, Tokunaga R, Miyamoto Y, et al. The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy. Int J Clin Oncol. 2023;28(3):400\u20138. https:\/\/doi.org\/10.1007\/s10147-023-02293-2.","journal-title":"Int J Clin Oncol."},{"issue":"1","key":"20608_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/etm.2010.175","volume":"2","author":"Y Toiyama","year":"2011","unstructured":"Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med. 2011;2(1):95\u2013101. https:\/\/doi.org\/10.3892\/etm.2010.175.","journal-title":"Exp Ther Med."},{"issue":"6","key":"20608_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","volume":"89","author":"LM Forrest","year":"2003","unstructured":"Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028\u201330. https:\/\/doi.org\/10.1038\/sj.bjc.6601242.","journal-title":"Br J Cancer."},{"key":"20608_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jss.2025.03.058","volume":"310","author":"T Horino","year":"2025","unstructured":"Horino T, Horiguchi H, Yumoto S, et al. Angiopoietin-like protein 2 expression is associated with host wasting-related poor prognosis in colorectal cancer. J Surg Res. 2025;310:239\u201348. https:\/\/doi.org\/10.1016\/j.jss.2025.03.058.","journal-title":"J Surg Res."},{"issue":"3","key":"20608_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ags3.12433","volume":"5","author":"Y Fujita","year":"2021","unstructured":"Fujita Y, Hida K, Hoshino N, et al. Impact of postoperative complications after primary tumor resection on survival in patients with incurable stage IV colorectal cancer: A multicenter retrospective cohort study. Ann Gastroenterol Surg. 2021;5(3):354\u201362. https:\/\/doi.org\/10.1002\/ags3.12433.","journal-title":"Ann Gastroenterol Surg."},{"issue":"5","key":"20608_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103374","volume":"9","author":"M Boukovala","year":"2024","unstructured":"Boukovala M, Modest DP, Ricard I, et al. Evaluation of the inflammation-based modified Glasgow Prognostic Score (mGPS) as a prognostic and predictive biomarker in patients with metastatic colorectal cancer receiving first-line chemotherapy: a post hoc analysis of the randomized phase III XELAVIRI trial (AIO KRK0110). ESMO Open. 2024;9(5):103374. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103374.","journal-title":"ESMO Open."},{"issue":"1","key":"20608_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.003.","journal-title":"Ann Oncol."},{"issue":"3","key":"20608_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101558","volume":"8","author":"T Yoshino","year":"2023","unstructured":"Yoshino T, Cervantes A, Bando H, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer. ESMO Open. 2023;8(3):101558. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101558.","journal-title":"ESMO Open."},{"issue":"11","key":"20608_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/diagnostics10110859","volume":"10","author":"W Son","year":"2020","unstructured":"Son W, Shin SJ, Park SH, et al. Clinical impact of combined modified Glasgow Prognostic Score and C-reactive protein\/albumin ratio in patients with colorectal cancer. Diagnostics (Basel). 2020;10(11):859. https:\/\/doi.org\/10.3390\/diagnostics10110859.","journal-title":"Diagnostics (Basel)."},{"issue":"9","key":"20608_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.annonc.2024.06.001","volume":"35","author":"DEW van der Kruijssen","year":"2024","unstructured":"van der Kruijssen DEW, Elias SG, van de Ven PM, et al. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group. Ann Oncol. 2024;35(9):769\u201379. https:\/\/doi.org\/10.1016\/j.annonc.2024.06.001.","journal-title":"Ann Oncol."},{"issue":"15","key":"20608_CR23","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.2026.1929","volume":"335","author":"EC Gootjes","year":"2026","unstructured":"Gootjes EC, Bakkerus L, Adhin AA, et al. Tumor debulking in combination with chemotherapy in multiorgan metastatic colorectal cancer: the ORCHESTRA randomized clinical trial. JAMA. 2026;335(15):1311\u201320. https:\/\/doi.org\/10.1001\/jama.2026.1929.","journal-title":"JAMA."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20608-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:38:55Z","timestamp":1789997935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20608-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":23,"alternative-id":["20608"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20608-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"17 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.W. has received honoraria for lectures from Covidien Japan, Johnson and Johnson, Eli Lilly, Terumo Corporation, and Takeda Pharmaceuticals and research funding from Covidien Japan, Stryker Japan, and Terumo Corporation outside of the submitted work. A.T. has received institutional research grants from MSD, Ono Pharmaceutical, Incyte, Daiichi Sankyo, Eisai, Bristol Myers Squibb, Bayer Yakuhin, Chugai Pharmaceutical, Taiho Pharmaceutical, BeiGene, Astellas Pharma, PRA Health Sciences, Seagen, AstraZeneca, Amgen, Boehringer Ingelheim, Maruho, Merck Biopharma, Janssen Pharmaceutical, Eli Lilly Japan, AbbVie, GlaxoSmithKline, Toray Industries, Jazz Pharmaceuticals Ireland, Elevation Oncology, and Shanghai Henlius Biotech and honoraria for lectures from Eli Lilly Japan, Ono Pharmaceutical, Taiho Pharmaceutical, Chugai Pharmaceutical, Takeda, and Merck Serono, all outside the submitted work.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}